Marchex Announces Fourth Quarter and Full Year 2025 Results and Archenia Transaction Update

Stock Information for Lisata Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Lisata Therapeutics Inc.

Are LSTA, MCHX, CZR Obtaining Fair Deals for their Shareholders?
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger-MCHX, HLX, CEPT, and PSBQ
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-TDAC, MCHX, NFBK, and CLBK
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Marchex, Inc. (NASDAQ: MCHX) 
Marchex Announces First Quarter 2026 Results and Archenia Transaction Update
Marchex Introduces Agent Behavior Solutions to Help Businesses Improve Sales Execution and Customer Experience
Marchex to Report First Quarter 2026 Financial Results on Wednesday, May 13, 2026
Marchex Engage Now Broadly Available to Help Businesses Act on Performance Gaps to Drive Revenue Growth

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.